Skip to main content
SpringerLink
Log in

Should α1-Antagonists be Avoided as First-Line Antihypertensive Therapy?

  • Letter to the Editor
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Guidelines Sub-Committee. 1999 World Health Organisation-International Society of Hypertension guidelines for the management of hypertension. J Hypertension 1999; 17: 151-84.

    Google Scholar 

  2. Messerli FH. Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipidlowering Treatment to Prevent Heart Attack Trial. Lancet 2000; 355: 863-64.

    PubMed  Google Scholar 

  3. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomised to doxazosin vs chlorthalidone: The Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000; 283: 1967-75.

    Google Scholar 

  4. Winniford MD, Filipchuk N, Hillis LD. Alpha-adrenergic blockade for variant angina: A long-term, double-blind, randomised trial. Circulation 1983; 67: 1185-88.

    PubMed  Google Scholar 

  5. Osnes JB, Aass H, Andersen GO, Skomedal T. First-line antihypertensive therapy. Lancet 2000; 356: 508-10.

    PubMed  Google Scholar 

  6. Salvi SS. Protecting the myocardium from ischemic injury: A critical role for α1-adrenoreceptors? Chest 2001; 119: 1242-1249.

    PubMed  Google Scholar 

  7. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.

    PubMed  Google Scholar 

  8. Malhotra R, Brosius FC, III. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiomyocytes. J Biol Chem 1999; 274: 12567-75.

    PubMed  Google Scholar 

  9. Opie LH. Hypothesis: Glycolytic rates control cell viability in ischemia. J Appl Cardiol 1988; 3: 407-14.

    Google Scholar 

  10. Doenst T, Taegtmeyer H. Alpha-adrenergic stimulation mediates glucose uptake through phosphatidylinositol 3-kinase in rat heart. Cir Res 1999; 84: 467-74.

    Google Scholar 

  11. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta-blockade after myocardial infarction: Systematic review and meta regression analysis. BMJ 1999; 318: 1730-37.

    PubMed  Google Scholar 

  12. Opie LH, Thomas M. Propranolol and experimental myocardial infarction: Substrate effects. Postgrad Med J 1976; 52: 124-32.

    PubMed  Google Scholar 

  13. Geor RJ, Hinchcliff KW, Sams RA. Beta-adrenergic blockade augments glucose utilization in horses during graded exercise. J Appl Physiol 2000; 89: 1086-98.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Southampton, Southampton, SO16 6YD, UK

    Sundeep S Salvi

Authors
  1. Sundeep S Salvi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salvi, S.S. Should α1-Antagonists be Avoided as First-Line Antihypertensive Therapy?. Cardiovasc Drugs Ther 15, 187–188 (2001). https://doi.org/10.1023/A:1011135231831

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011135231831

Search

Navigation